Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|23|3691-3698

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.23, 2014-12, pp. : 3691-3698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Follicular-fluid anti-Mullerian hormone concentrations are predictive of assisted reproduction outcome in PCOS patients

By Pabuccu Recai   Kaya Cemil   Cağlar Gamze Sinem   Oztas Efser   Satiroglu Hakan  

Reproductive BioMedicine Online, Vol. 19, Iss. 5, 2009-11 ,pp. : 631-637

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

A deletion in chromosome 11q may predict the response to anthracycline-based chemotherapy in patients with early node-negative breast cancer

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Gefitinib alone or in combination with anastrozole reduces tumour-cell proliferation and tumour size in patients with breast cancer

By  

Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Association between antidepressants and breast/ovarian cancer

By Pae Chi-Un  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 441-444

Informa Healthcare

Access to resources Recommend Favorite

Risks and Benefits of Taxanes in Breast and Ovarian Cancer

By Michaud L.B.  

Drug Safety, Vol. 23, Iss. 5, 2000-11 ,pp. : 401-428

Adis International

Access to resources Recommend Favorite